30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Epica Gains FDA Clearance for SeeFactorCT3 -

Epica was granted FDA 510(k) clearance to market the SeeFactorCT3™ Imaging Platform, comprising computed tomography, fluoroscopy and digital radiography in one system. The diagnostic, interventional and intraoperative imaging system can obtain ultra high-resolution 3D volumetric images throughout the body, and can serve as a primary imaging modality for practically all musculoskeletal applications. The system is lightweight and maneuverable, and is suitable not only for imaging or operating rooms, but also ambulatory/outpatient centers and emergency rooms. Having obtained FDA clearance, the company will now focus on development of a medical robot to integrate with CT imaging. The connection would allow the robot to be guided by SeeFactorCT3’s ultra-high resolution images. (Epica International, 10/2/19)